Scarica l'app Stockscreener
24.47
2.86%
-0.72
Dopo l'orario di chiusura:
24.15
-0.32
-1.31%
Newamsterdam Pharma Company Nv Borsa (NAMS) Ultime notizie
How sentiment analysis helps forecast NewAmsterdam Pharma Company N.V.Quarterly Market Summary & Risk Controlled Daily Trade Plans - Newser
What earnings revisions data tells us about NewAmsterdam Pharma Company N.V. Equity WarrantPortfolio Performance Summary & Fast Entry High Yield Tips - Newser
Full technical analysis of NewAmsterdam Pharma Company N.V. Equity Warrant stockJuly 2025 Snapshot & Free Low Drawdown Momentum Trade Ideas - Newser
What to expect from NewAmsterdam Pharma Company N.V. in the next 30 daysPortfolio Value Summary & Stepwise Trade Execution Plans - Newser
NewAmsterdam announces acceptance of MAA for review by EMA for obicetrapib - MSN
Predicting NewAmsterdam Pharma Company N.V. trend using moving averagesEarnings Growth Report & Expert Verified Movement Alerts - Newser
What earnings revisions data tells us about NewAmsterdam Pharma Company N.V.Stop Loss & Growth Focused Investment Plans - Newser
Is NewAmsterdam Pharma Company N.V. Equity Warrant a candidate for recovery playQuarterly Profit Review & Free Expert Approved Momentum Trade Ideas - Newser
Price action breakdown for NewAmsterdam Pharma Company N.V. Equity WarrantMarket Growth Summary & Breakout Confirmation Alerts - Newser
How to integrate NewAmsterdam Pharma Company N.V. Equity Warrant into portfolio analysis toolsJuly 2025 Earnings & Reliable Entry Point Alerts - Newser
NewAmsterdam Pharma Company N.V. stock prediction for this weekPortfolio Value Report & Real-Time Volume Analysis Alerts - Newser
Historical volatility pattern of NewAmsterdam Pharma Company N.V. visualizedTrade Analysis Report & Daily Growth Stock Investment Tips - Newser
Using Ichimoku Cloud for NewAmsterdam Pharma Company N.V. Equity Warrant technicalsTake Profit & Weekly High Potential Alerts - Newser
How sentiment analysis helps forecast NewAmsterdam Pharma Company N.V. Equity WarrantWeekly Trade Report & Weekly High Potential Stock Alerts - Newser
Analyzing NewAmsterdam Pharma Company N.V. with risk reward ratio charts2025 Market Sentiment & AI Optimized Trade Strategies - Newser
NewAmsterdam Pharma Company N.V. Equity Warrant stock momentum explainedMarket Activity Report & Risk Controlled Daily Trade Plans - Newser
Short interest data insights for NewAmsterdam Pharma Company N.V.Index Update & Fast Entry High Yield Stock Tips - Newser
Newamsterdam Pharma shares rise 1.86% intraday after insider sold shares. - AInvest
Momentum divergence signals in NewAmsterdam Pharma Company N.V. chart2025 Market Outlook & Daily Stock Momentum Reports - Newser
Real time breakdown of NewAmsterdam Pharma Company N.V. stock performanceGlobal Markets & Risk Adjusted Swing Trade Ideas - Newser
Using R and stats models for NewAmsterdam Pharma Company N.V. forecasting2025 Technical Patterns & Free Expert Approved Momentum Trade Ideas - Newser
What’s the recovery path for long term holders of NewAmsterdam Pharma Company N.V.Weekly Stock Summary & AI Powered Market Entry Ideas - Newser
Comparing NewAmsterdam Pharma Company N.V. Equity Warrant in custom built stock radarsMarket Growth Review & Accurate Technical Buy Alerts - Newser
Published on: 2025-08-25 21:09:41 - beatles.ru
NewAmsterdam Pharma Company N.V. Equity Warrant’s volatility index tracking explainedGlobal Markets & Reliable Intraday Trade Plans - Newser
NewAmsterdam Pharma to Participate in Upcoming Medical Meeting and Investor Conferences in September - GlobeNewswire
Major Phase 3 Data Coming: NewAmsterdam's Novel Cholesterol Drug Results at ESC Congress 2025 - Stock Titan
NewAmsterdam Pharma stock initiated at Overweight by Wells Fargo - Investing.com
Can NewAmsterdam Pharma Company N.V. recover in the next quarterJuly 2025 Levels & Safe Capital Investment Plans - Newser
Does NewAmsterdam Pharma Company N.V. qualify in momentum factor screeningMarket Performance Summary & Risk Controlled Swing Alerts - Newser
Is NewAmsterdam Pharma Company N.V. trending in predictive chart models2025 Investor Takeaways & Safe Capital Growth Plans - Newser
Smart tools for monitoring NewAmsterdam Pharma Company N.V.’s price action - Newser
Institutional scanner results for NewAmsterdam Pharma Company N.V. Equity WarrantPortfolio Value Report & AI Powered Market Trend Analysis - Newser
NewAmsterdam Pharma Company N.V. Chart Enters High Volatility ZoneJuly 2025 Setups & Risk Controlled Stock Pick Alerts - beatles.ru
Short Term Trend Reversal in NewAmsterdam Pharma Company N.V. PossibleJuly 2025 EndofMonth & Expert Verified Stock Movement Alerts - beatles.ru
CDMO Piramal Pharma Solutions NewAmsterdam Pharma Partner To Expand Oral Solid Dosage Production At Sellersville PA Manufacturing Site - Pharmaceutical Online
Is NewAmsterdam Pharma Company N.V. Equity Warrant’s ROE strong enoughJuly 2025 Sector Moves & Daily Volume Surge Trade Alerts - theviewers.co.kr
Can NewAmsterdam Pharma Company N.V. Equity Warrant stock double in the next yearPortfolio Update Report & Fast Entry High Yield Stock Tips - theviewers.co.kr
Piramal, NewAmsterdam Pharma Open Dedicated OSD Form Suite - Contract Pharma
Visual analytics tools that track NewAmsterdam Pharma Company N.V. performanceJuly 2025 News Drivers & Technical Analysis for Trade Confirmation - Newser
Piramal Pharma Solutions and NewAmsterdam Pharma Invest in Dedicated Suite to Enhance Oral Solid Dosage Production Capabilities at Piramal's Sellersville, Pennsylvania Site - Yahoo Finance
Piramal Pharma Solutions and NewAmsterdam Pharma Invest in Dedicated Suite to Enhance Oral Solid Dosage Production Capabilities at Piramal's Sellersville, Pennsylvania Site – Company AnnouncementFT.com - Financial Times
0.98%
8.06%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):